purpose macular degeneration prevalent etiology subfoveal choroidal neovascularization cnv effective treatment laser photocoagulation associated decreased visual acuity following treatment patients study assessed response subfoveal cnv proton beam irradiation morbidity evaluated preliminary results patients treated initial dose NUMBER cobalt gray equivalents cge using relative biological effectiveness rbe NUMBER methods materials patients subfoveal cnv received proton irradiation central macula single fraction NUMBER cge NUMBER eligible evaluation morbidity based radiation therapy oncology group rtog criteria response evaluated macular photocoagulation study mps guidelines fluorescein angiography performed visual acuity contrast sensitivity reading speed measured study entry intervals treatment ranged NUMBER NUMBER months results measurable morbidity seen treatment NUMBER patients evaluated NUMBER months fluorescein angiography demonstrated treatment response NUMBER NUMBER NUMBER NUMBER patients improved stable visual acuity mean NUMBER months NUMBER NUMBER patients demonstrated improved stable visual acuity conclusion macular dose NUMBER cge yielded measurable treatment morbidity patients studied fluorescein angiography demonstrated regressed stabilized lesions associated improved visual acuity compared mps results phase dose NUMBER cge single fraction used define optimal dose fractionation schedule age related treatment related treatment related NUMBER month follow treatment related follow